At Stock Options Channel, our YieldBoost formula has looked up and down the MRNA options chain for the new May 16th contracts and identified one put and one call contract of particular interest.

At Stock Options Channel, our YieldBoost formula has looked up and down the MRNA options chain for the new April 11th contracts and identified the following call contract of particular interest.

In a new study published recently in the journal Cell Reports, Yale researchers reveal that mRNA, or messenger RNA, plays a significant role in cell migration, a duty that also dramatically ...

During translation, multiple ribosomes travel along the nucleic acid chain to build polypeptides that become functional proteins. Occasionally, these molecular decoders pause on the mRNA, either ...

As STAT’s Helen Branswell writes, mRNA vaccines are the fastest to make and the easiest to mass produce.

Moderna (NasdaqGS:MRNA) recently faced significant legal challenges with five international lawsuits from Genevant Sciences and Arbutus Biopharma targeting its LNP technology used in products like ...

Want to share this FREE webinar with a colleague? Fill out the form below and we'll send your colleague an invitation to the "Optimizing mRNA Manufacturing: Overcoming Supply Chain Challenges With ...

Currently, mRNA vaccines require expensive and challenging end-to-end, ultra-cold-chain distribution and storage requirements, a significant barrier to vaccine accessibility in low-and middle ...

Blood–brain-barrier-crossing lipid nanoparticles for mRNA delivery to the central nervous system. Nature Materials , 2025; DOI: 10.1038/s41563-024-02114-5 Cite This Page : ...